From enabling personalised medicine to accelerating the drug development pathway, 3D printing offers huge potential in pharmaceutical manufacturing. But in order to embrace this new world of opportunities, we need a deeper understanding of the materials, processes and techniques involved.

New research initiated and supported by DFE Pharma, underlines the benefits of 3D powder bed printed tablets with a blend of lactose monohydrate and pregelatinized starch as main carrier system.

We believe that by pooling our resources and knowledge, industry, innovators and academia can build the common evidence base we need to produce the medicines of the future.

Learn more: [ Ссылка ]

свернуть